Abstract
Green fluorescent proteins (GFPs) and their derivatives are widely used as markers to visualize cells, protein localizations in in vitro and in vivo studies. The use of GFP fusion protein for visualization is generally thought to have negligible effects on cellular function. However, a number of reports suggest that the use of GFP may impact the biological activity of these proteins. Heparin is a glycosaminoglycan (GAG) that interacts with a number of proteins mediating diverse patho-physiological processes. In the heparin-based interactome studies, heparin-binding proteins are often prepared as GFP fusion proteins. In this report, we use surface plasmon resonance (SPR) spectroscopy to study the impact of the GFP tagging on the binding interaction between heparin and a heparin-binding protein, the Roundabout homolog 1 (Robo1). SPR reveals that heparin binds with higher affinity to Robo1 than GFP-tagged Robo1 and through a different kinetic mechanism. A conformational change is observed in the heparin-Robo1 interaction, but not in the heparin-Robo1-GFP interaction. Furthermore the GFP-tagged Robo1 requires a shorter (hexasaccharide) than the tag-free Robo1 (octadecasaccharide). These data demonstrate that GFP tagging can reduce the binding affinity of Robo1 to heparin and hinder heparin binding-induced Robo1 conformation change.
Similar content being viewed by others
Abbreviations
- GFPs:
-
Green fluorescent proteins
- SPR:
-
Surface plasmon resonance
- GAG:
-
Glycosaminoglycan
- Robo1:
-
Roundabout homolog 1
- HEPES:
-
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
- HS:
-
Heparan sulfate
- RU:
-
Resonance unit
- dp:
-
Degree of polymerization
References
Shimomura, O., Johnson, F.H., Saiga, Y.: Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. J. Cell. Comp. Physiol. 59, 223–239 (1962)
Kremers, G.J., Gilbert, S.G., Cranfill, P.J., Davidson, M.W., Piston, D.W.: Fluorescent proteins at a glance. J. Cell Sci. 124, 157–160 (2011)
Ormo, M., Cubitt, A.B.., Kallio, K., Gross, L.A., Tsien, R.Y., Remington, S.J.: Crystal structure of the Aequorea victoria green fluorescent protein. Science 273, 1392–1395 (1996)
Remington, S.J.: Fluorescent proteins: maturation, photochemistry and photophysics. Curr. Opin. Struct. Biol. 16, 714–721 (2006)
Yarbrough, D., Wachter, R.M., Kallio, K., Matz, M.V., Remington, S.J.: Refined crystal structure of DsRed, a red fluorescent protein from coral, at 2.0-A resolution. Proc. Natl. Acad. Sci. U. S. A. 98, 462–467 (2001)
Petersen, J., Wilmann, P.G., Beddoe, T., Oakley, A.J., Devenish, R.J., Prescott, M., Rossjohn, J.: The 2.0-A crystal structure of eqFP611, a far red fluorescent protein from the sea anemone Entacmaea quadricolor. J. Biol. Chem. 278, 44626–44631 (2003)
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W., Prasher, D.C.: Green fluorescent protein as a marker for gene expression. Science 263, 802–805 (1994)
Davidson, M.W., Campbell, R.E.: Engineered fluorescent proteins: innovations and applications. Nat. Methods 6, 713–717 (2009)
Agbulut, O., Coirault, C., Niederlander, N., Huet, A., Vicart, P., Hagege, A., Puceat, M., Menasche, P.: GFP expression in muscle cells impairs actin-myosin interactions: implications for cell therapy. Nat. Methods 3, 331 (2006)
Agbulut, O., Huet, A., Niederlander, N., Puceat, M., Menasche, P., Coirault, C.: Green fluorescent protein impairs actin-myosin interactions by binding to the actin-binding site of myosin. J. Biol. Chem. 282, 10465–10471 (2007)
Baens, M., Noels, H., Broeckx, V., Hagens, S., Fevery, S., Billiau, A.D., Vankelecom, H., Marynen, P.: The dark side of EGFP: defective polyubiquitination. PLoS One 1, e54 (2006)
Liu, H.S., Jan, M.S., Chou, C.K., Chen, P.H., Ke, N.J.: Is green fluorescent protein toxic to the living cells? Biochem. Biophys. Res. Commun. 260, 712–717 (1999)
Mak, G.W., Wong, C.H., Tsui, S.K.: Green fluorescent protein induces the secretion of inflammatory cytokine interleukin-6 in muscle cells. Anal. Biochem. 362, 296–298 (2007)
Koelsch, K.A., Wang, Y., Maier-Moore, J.S., Sawalha, A.H., Wren, J.D.: GFP affects human T cell activation and cytokine production following in vitro stimulation. PLoS One 8, e50068 (2013)
Huang, W.Y., Aramburu, J., Douglas, P.S., Izumo, S.: Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat. Med. 6, 482–483 (2000)
Krestel, H.E., Mihaljevic, A.L., Hoffman, D.A., Schneider, A.: Neuronal co-expression of EGFP and beta-galactosidase in mice causes neuropathology and premature death. Neurobiol. Dis. 17, 310–318 (2004)
Capila, I., Linhardt, R.J.: Heparin-protein interactions. Angew. Chem. Int. Ed. Engl. 41, 391–412 (2002)
Hacker, U., Nybakken, K., Perrimon, N.: Heparan sulphate proteoglycans: the sweet side of development. Nat. Rev. Mol. Cell Biol. 6, 530–541 (2005)
Parish, C.R.: The role of heparan sulphate in inflammation. Nat. Rev. Immunol. 6, 633–643 (2006)
Powell, A.K., Yates, E.A., Fernig, D.G., Turnbull, J.E.: Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches. Glycobiology 14, 17R–30R (2004)
Sasisekharan, R., Raman, R., Prabhakar, V.: Glycomics approach to structure-function relationships of glycosaminoglycans. Annu. Rev. Biomed. Eng. 8, 181–231 (2006)
Qiu, H., Jiang, J.L., Liu, M., Huang, X., Ding, S.J., Wang, L.: Quantitative phosphoproteomics analysis reveals broad regulatory role of heparan sulfate on endothelial signaling. Mol. Cell. Proteomics 12, 2160–2173 (2013)
Wang, L., Fuster, M., Sriramarao, P., Esko, J.D.: Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat. Immunol. 6, 902–910 (2005)
Brose, K., Bland, K.S., Wang, K.H., Arnott, D., Henzel, W., Goodman, C.S., Tessier-Lavigne, M., Kidd, T.: Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell 96, 795–806 (1999)
Jones, C.A., et al.: Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat. Med. 14, 448–453 (2008)
Zhang, B., Dietrich, U.M., Geng, J.G., Bicknell, R., Esko, J.D., Wang, L.: Repulsive axon guidance molecule Slit3 is a novel angiogenic factor. Blood 114, 4300–4309 (2009)
Condac, E., et al.: The C-terminal fragment of axon guidance molecule Slit3 binds heparin and neutralizes heparin's anticoagulant activity. Glycobiology 22, 1183–1192 (2012)
Barb, A.W., Meng, L., Gao, Z., Johnson, R.W., Moremen, K.W., Prestegard, J.H.: NMR characterization of immunoglobulin G Fc glycan motion on enzymatic sialylation. Biochemistry 51, 4618–4626 (2012)
Vandersall-Nairn, A.S., Merkle, R.K., O'Brien, K., Oeltmann, T.N., Moremen, K.W.: Cloning, expression, purification, and characterization of the acid alpha-mannosidase from Trypanosoma cruzi. Glycobiology 8, 1183–1194 (1998)
Beckett, D., Kovaleva, E., Schatz, P.J.: A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation. Protein Sci. 8, 921–929 (1999)
Pedelacq, J.D., Cabantous, S., Tran, T., Terwilliger, T.C., Waldo, G.S.: Engineering and characterization of a superfolder green fluorescent protein. Nat. Biotechnol. 24, 79–88 (2006)
Hernaiz, M., Liu, J., Rosenberg, R.D., Linhardt, R.J.: Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III. Biochem. Biophys. Res. Commun. 276, 292–297 (2000)
Prince, R.N., Schreiter, E.R., Zou, P., Wiley, H.S., Ting, A.Y., Lee, R.T., Lauffenburger, D.A.: The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release. J. Cell Sci. 123, 2308–2318 (2010)
Schmidt, M., Govindasamy, L., Afione, S., Kaludov, N., Agbandje-McKenna, M., Chiorini, J.A.: Molecular characterization of the heparin-dependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV(VR-942). J. Virol. 82, 8911–8916 (2008)
Tavaré, J.M., Fletcher, L.M., Welsh, G.I.: Using green fluorescent protein to study intracellular signalling. J. Endocrinol. 170, 297–306 (2001)
Fukuhara, N., Howitt, J.A., Hussain, S.A., Hohenester, E.: Structural and functional analysis of slit and heparin binding to immunoglobulin-like domains 1 and 2 of Drosophila Robo. J. Biol. Chem. 283, 16226–16234 (2008)
Olson, S.T., Bjork, I., Sheffer, R., Craig, P.A., Shore, J.D., Choay, J.: Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J. Biol. Chem. 267, 12528–12538 (1992)
Zhang, F., Moniz, H.A., Walcott, B., Moremen, K.W., Linhardt, R.J., Wang, L.: Characterization of the interaction between Robo1 and heparin/glycosaminoglycans. Biochemie 95, 2345–2353 (2013)
Futamura, M., Dhanasekaran, P., Handa, T., Phillips, M.C., Lund-Katz, S., Saito, H.: Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces. J. Biol. Chem. 280, 5414–5422 (2005)
Schlessinger, A., Rost, B.: Protein flexibility and rigidity predicted from sequence. Proteins 61, 115–126 (2005)
Schlessinger, A., Punta, M., Rost, B.: Natively unstructured regions in proteins identified from contact predictions. Bioinformatics 23, 2376–2384 (2007)
Schlessinger, A., Punta, M., Yachdav, G., Kajan, L., Rost, B.: Improved disorder prediction by combination of orthogonal approaches. PLoS ONE 4, e4433 (2009)
Acknowledgments
This work was supported by grants from the National Institutes of Health in the form of GM-38060 to R.J.L. and NIH R01HL093339 (L.W.), RR005351/GM103390 (L.W. and K.M.)
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhang, F., Moniz, H.A., Walcott, B. et al. Probing the impact of GFP tagging on Robo1-heparin interaction. Glycoconj J 31, 299–307 (2014). https://doi.org/10.1007/s10719-014-9522-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-014-9522-1